(Q63977062)

1

object named as

Charles R Scoggins

0 references

Robert C G Martin

12

object named as

Robert C G Martin

0 references

author name string

Merrick I Ross

2

0 references

Douglas S Reintgen

3

0 references

R Dirk Noyes

4

0 references

James S Goydos

5

0 references

Peter D Beitsch

6

0 references

Marshall M Urist

7

0 references

Stephan Ariyan

8

0 references

Jeffrey J Sussman

9

0 references

Michael J Edwards

10

0 references

Anees B Chagpar

11

0 references

Arnold J Stromberg

13

0 references

Lee Hagendoorn

The prognostic significance of ulceration of cutaneous melanoma

14

0 references

language of work or name

English

0 references

publication date

May 2006

0 references

published in

Annals of Surgery

0 references

volume

243

0 references

page(s)

693-8; discussion 698-700

0 references

issue

5

0 references

cites work

1 reference

12 December 2020

A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma

1 reference

12 December 2020

Tumor thickness and prognosis in clinical stage I malignant melanoma

1 reference

12 December 2020

Model predicting survival in stage I melanoma based on tumor progression

1 reference

12 December 2020

Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen

1 reference

12 December 2020

Cutaneous melanoma: prognosis and treatment results worldwide

1 reference

12 December 2020

Tamoxifen as a single agent for advanced melanoma in postmenopausal women. A phase II study of the EORTC Malignant Melanoma Cooperative Group

1 reference

12 December 2020

Review and current perspectives of cutaneous malignant melanoma

1 reference

12 December 2020

Age as a prognostic factor in the malignant melanoma population

1 reference

12 December 2020

Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.

1 reference

12 December 2020

The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921).

1 reference

12 December 2020

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

1 reference

12 December 2020

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma

1 reference

12 December 2020

Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma

1 reference

12 December 2020

Investigation of female survival benefit in metastatic melanoma

1 reference

12 December 2020

Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma

1 reference

12 December 2020

Histologic features of tumors and the female superiority in survival from malignant melanoma

1 reference

12 December 2020

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma

1 reference

12 December 2020

A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma

1 reference

12 December 2020

Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma

1 reference

12 December 2020

Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma

1 reference

12 December 2020

The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma

1 reference

12 December 2020

Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence

1 reference

12 December 2020

Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?

1 reference

12 December 2020

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients.

1 reference

12 December 2020

The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.

1 reference

12 December 2020

Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma

1 reference

12 December 2020

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

1 reference

12 December 2020

Patterns of early recurrence after sentinel lymph node biopsy for melanoma

1 reference

12 December 2020

Sentinel Lymph Node Mapping for Thick (?4-mm) Melanoma: Should We Be Doing It?

1 reference

12 December 2020

Use of tamoxifen in the treatment of malignant melanoma

1 reference

12 December 2020

Correlation between prognostic factors and increasing age in melanoma.

1 reference

12 December 2020

Lessons learned from the Sunbelt Melanoma Trial

1 reference

12 December 2020

Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma

1 reference

12 December 2020

Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma

1 reference

12 December 2020

A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods

1 reference

12 December 2020

Tumor thickness as a guide to surgical management of clinical stage I melanoma patients

1 reference

12 December 2020

A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia

1 reference

12 December 2020